Latest Synedgen Inc. Stories
Wound Rinse Removes Bacteria and Biofilms and Enhances Healing Claremont CA (PRWEB) May 05, 2013 Removing embedded bacteria from biofilms in wounds remains a challenge to doctors and caregivers. Likewise, veterinarians face similar challenges treating their zoo patients. Synedgen will report compelling data on new treatments against wound biofilms at a poster session at the 113th General Meeting of the American Society for Microbiology (asm2013) on May 18-21, 2013, at the Colorado...
Synedgen Active Agent reduces mortality in animals after exposure to lethal ionizing radiation. Claremont, CA (PRWEB) September 30, 2012 Due to the success of an Army funded, preliminary study showing dramatic reduction in animal mortality after treatment with Synedgen’s therapeutic for lethal ionizing radiation, the U.S. Army Medical Research Acquisition Activity has awarded supplemental funding totaling $213,550 to further Synedgen’s work in radiation protection. The Army’s...
Synedgen’s active ingredient disrupts bacterial biofilms. (PRWEB) September 09, 2012 Synedgen VP of Research, Stacy Townsend PhD, will present research showcasing Synedgen’s unique technology to control wound biofilms and inflammation at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), the world’s premier international conference on antimicrobial agents and infectious diseases in San Francisco on September 11. The presentation entitled, “Novel...
Synoplex® treats infected, chronic and non-infected wounds in elephants and rhinoceroses, Claremont CA (PRWEB) July 01, 2012 Elephants and Rhinoceroses frequently encounter chronic non-healing infected abscesses and cutaneous wounds that become resistant to traditional antibiotics and treatments. Over time, these wounds can have serious long-term consequences such as systemic infections and impaired mobility. Recognizing the difficulty in treating these types of wounds, the FDA’s...
Synedgen Reports Promising Radiation Treatment Data Claremont, CA (PRWEB) June 08, 2012 Federal agencies are highly concerned about potential dangers to the US population by radiation exposures such as the nuclear incident in Japan or the threat of a terrorist dirty bomb. Synedgen has already demonstrated success in reducing severe oral ulcerations and inflammation in a model of radiation-induced oral mucositis and reducing damage and inflammation in the GI tract after chemical or...
Synedgen Inc. and Europharma Concepts Ltd. announce joint license, supply, and distribution agreement to develop and market oral care products based on Synedgen’s proprietary SYN01 technology. Claremont, CA (PRWEB) March 14, 2012 Synedgen Inc. and Europharma Concepts Ltd. are pleased to announce that they have entered into a joint license, supply, and distribution agreement to develop and market oral care products based on Synedgen’s proprietary SYN01 technology. The companies will...
Synedgen Study Shows Chitosan Derivative Reduces Risk of Food Contamination. Claremont CA (PRWEB) February 11, 2012 Claremont CA, January 24, 2012--Research conducted by Synedgen Inc. and the School of Environment, Natural Resources & Geography, at Bangor University, Bangor, UK, appears in the early view of Food Control, an international, official scientific journal of the European Federation of Food Science and Technology (EFFoST) covering microbial food safety and antimicrobial...
Chitosan Derivatives Reduce E. coli and coliform concentrations in models of food contamination (PRWEB) July 15, 2011 New research conducted jointly between Synedgen, Inc, and the School of Environment, Natural Resources and Geography, at Bangor University, Bangor, UK demonstrates that a novel biocompatible and bactericidal chitosan derivative developed by Synedgen offers a rapid and safe method to significantly reduce bacterial counts and inhibit pathogenic activity from dangerous...
Wound Rinse Removes Bacteria and Biofilms Without Damaging Tissue (PRWEB) May 20, 2011 Synedgen will report recent data from its studies of a new wound rinse at a poster session May 23 at ASM 2011, the annual meeting of the American Society for Microbiology in New Orleans. The poster, Novel Antibacterial Chitosan Derivatives with Residual Activity Reduce Multi-Drug Resistant Biofilms and Remove Bacteria from Abraded Skin, highlights the antibacterial and biofilm-reducing activity of...
